The treatment of cancer is evolving at a rapid pace around the world. Key to this is accurate diagnosis and tailored treatment plans that are patient specific. We aim to bring cutting edge genetic screening services to market that are significantly more affordable than currently used service providers. In conjunction with that innovative solutions to ensuring optimal dosing solutions that tailor the treatment regime according to the patients ability to metabolize the treatments. Patients with impaired liver and/or kidney function, or paediatric patients need particular care to ensure that the dosing is delivered accurately.